Ariad Pharmaceuticals Inc fka ARIA

[BTH]

So, no, you can't say on one hand the PFS is only going to be "weeks" and at the same time give the trial a 60% chance of succeeding

How do you come to that conclusion unless you have also spoken with dozens of Key Opinion Leaders (experts) on the drug, about the SUCCEED trial (like Leerink (who owns MEDACORP - a network of thousands of doctors, many of whom have participated in treating these patients many times); JP Morgan, LEHM, JEFF all have the same access, and all agree upon the same thing 0 which is what JEFF reported yesterday -that ridaforolimus "may" succeed - that sounds like a crap-shoot to me.

Like I said, these analysts aren't very good at picking stocks, but they do have all the information at their disposal.

I'm curious if you have access to this information as well.